<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221125056601N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-12-28</date_registration>
      <primary_sponsor>Semarang Health Polytechnic</primary_sponsor>
      <public_title>Pulse-based food supplements for undernourished pregnant mothers</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of pulse-based food supplements for undernourished pregnant mothers to improve maternal and birth outcomes: a cluster randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/67047</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: The sample size was calculated using STATA 15 command of "clustersampsi, binomial power  p1(0.55) p2(0.12)  m(4) k(10) rho(0.01) size_cv(0.9) base_correl(0)~" resulting 60 participants per group, Randomization description: This will be cluster randomization with a village as a unit of assignment. We will use the random number formula in an Excel spreadsheet. In order to have a balanced number of pregnant women in the intervention and control group, stratified randomization will be used based on the number of undernourished pregnant mothers in the village (3-6, and &gt;=7 ). A statistician will perform randomization of the 20 villages for the intervention and control group, and then the field researcher will execute the result, Blinding description: The participants will be blinded. 
The nature of the dietary intervention study is impractical to blind the cooks, dietitians and the study staff responsible for preparing the foods and taking all measurements of the diets. An effort will be made to blind the study participants in the intervention assignment, including
1.	The participants will not be told of their group assignment
2.	The study will employ a cluster randomized controlled trial, with a village as a unit of assignment. Therefore, the two groups will consume their food supplement in separate villages and presumably will not meet each other. 
3.	Both groups will receive food and nutrient supplements using similar nutrient content. The intervention group will receive ‘pulse cookies’ as food supplements combined with multiple micronutrients and the one for control will receive fortified food supplements as the government program.  
4.	Both groups will receive nutrition education in different classes, places, and schedules.</study_design>
      <phase>3</phase>
      <hc_freetext>Pregnant mothers with mid-upper arm circumference (MUAC) &lt;23.5cm.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group. The intervention group will receive firstly, ‘Pulse based cookies’ as local food supplements (PFS), approximately  80-85 grams cookies that contain 400-450 kcal energy, 10-13 grams protein, and 22-30 grams fat. PBC consist of 8 types of cookies, each cookie is made from pulses (i.e. soybean, green bean, red bean, or brown bean), vegetable oil, white sugar, egg, instant yeast, guar gum, skim milk, peanut or coconut, and salt. Secondly, Multiple micronutrition supplementation (MMS) as UNIMMAP that contain Vitamin A (as palmitate or acetate)  800 µg RE (2667 IU), Vitamin C (Ascorbic acid)  70 mg, Vitamin D (as 5 µg Cholecalciferol)  5 µg (200 IU), Vitamin E (10 mgα-TE) (as dl-alpha tocopheryl acetate)  15 IU, Vitamin B1 (Thiamine mononitrate)  1.4 mg, Vitamin B2 (Riboflavin)  1.4 mg, Vitamin B3 (Niacinamide)  18 mg, Vitamin B6 (Pyridoxine HCl)  1.9 mg , Folate (from Folic Acid) 680 µg DFE (400 µg Folic Acid), Vitamin B12 (Cyanocobalamin)   2.6 µg, Iron (Ferrous Fumarate)  30 mg , Iodine (Potassium Iodide)  150 µg , Zinc (Zinc Sulphate)   15 mg, Selenium (Sodium Selenite)  65 µg , Copper (Copper Citrate)   2 mg. Third, a 1-day class training on maternal health and early life nutrition. The trainers will be from PHCs and the researchers. The trainers will be provided with PowerPoint presentation slides, while participants will receive two booklets of the slides. The supplements (PFS and MMS) will be given for 90 days duration, and a package of 30 days’ supplements will be given at the training and another 60 days’ package will be delivered at week four and eight. Intervention 2: Control group. The control group will receive firstly, the Government food supplements (GFS), approximately 60 grams cookies that contain 300 kcal energy, 3 grams protein, and 22-30 grams fat. The GFS is fortified with multiple micronutrition, namely energy 300 Kcal , Total fat  15.6 g, Protein   3 g, Carbohydrate 34.8 g, Natrium 141 mg, Vitamin A  275.22 RE, Vitamin D  7.5 mcg, Vitamin E 7.08 mg, Vitamin B1 0.48 mg, Vitamin B2 0.48 mg, Vitamin B3  5.34 mg, Vitamin B5  1.8 mg, Vitamin B6  0.54 mg, Vitamin B9  198 mcg, Vitamin B12  0.84 mcg, Vitamin C 28.2 mg, Calcium   261.6 mg, Phosphor  194.4 mg, iron  6.96 mg, Iodium 51.6 mg, Zink  4.2 mg, Selenium 19.2 mcg, Fluor 0.18 mg,  water  1.764 g. Secondly, a 1-day class training on maternal health and early life nutrition. The trainers will be from PHCs and the researchers. The trainers will be provided with PowerPoint presentation slides, while participants will receive two booklets of the slides. The GFS will be given for 90 days duration, and a package of 30 days’ supplements will be given at the training and another 60 days’ package will be delivered at week four and eight.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Kun A Susiloretni</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jl. Wolter Monginsidi 115</address>
        <city>Semarang</city>
        <country1>Indonesia</country1>
        <zip>50192</zip>
        <telephone>+62 622 46710378</telephone>
        <email>kun@poltekkes-smg.ac.id</email>
        <affiliation>Semarang Health Polytechnic</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Kun A Susiloretni</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Jl. Wolter Monginsidi 115</address>
        <city>Semarang</city>
        <country1>Indonesia</country1>
        <zip>50192</zip>
        <telephone>+62 622 46710378</telephone>
        <email>kun@poltekkes-smg.ac.id</email>
        <affiliation>Semarang Health Polytechnic</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Indonesia</country2>
      <country2>Indonesia</country2>
    </countries>
    <criteria>
      <inclusion_criteria>pregnant women with mid-upper arm circumference (MUAC) &lt;23.5 cm
gestational age at less than 28  weeks
single pregnancy
had no intention of moving from the area for at least 6 months
had visited village midwives for antenatal care</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>pregnant women had experienced previous stillbirth or miscarriage</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>O25.11</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Malnutrition in pregnancy, first trimester</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group. The intervention group will receive firstly, ‘Pulse based cookies’ as local food supplements (PFS), approximately  80-85 grams cookies that contain 400-450 kcal energy, 10-13 grams protein, and 22-30 grams fat. PBC consist of 8 types of cookies, each cookie is made from pulses (i.e. soybean, green bean, red bean, or brown bean), vegetable oil, white sugar, egg, instant yeast, guar gum, skim milk, peanut or coconut, and salt. Secondly, Multiple micronutrition supplementation (MMS) as UNIMMAP that contain Vitamin A (as palmitate or acetate)  800 µg RE (2667 IU), Vitamin C (Ascorbic acid)  70 mg, Vitamin D (as 5 µg Cholecalciferol)  5 µg (200 IU), Vitamin E (10 mgα-TE) (as dl-alpha tocopheryl acetate)  15 IU, Vitamin B1 (Thiamine mononitrate)  1.4 mg, Vitamin B2 (Riboflavin)  1.4 mg, Vitamin B3 (Niacinamide)  18 mg, Vitamin B6 (Pyridoxine HCl)  1.9 mg , Folate (from Folic Acid) 680 µg DFE (400 µg Folic Acid), Vitamin B12 (Cyanocobalamin)   2.6 µg, Iron (Ferrous Fumarate)  30 mg , Iodine (Potassium Iodide)  150 µg , Zinc (Zinc Sulphate)   15 mg, Selenium (Sodium Selenite)  65 µg , Copper (Copper Citrate)   2 mg. Third, a 1-day class training on maternal health and early life nutrition. The trainers will be from PHCs and the researchers. The trainers will be provided with PowerPoint presentation slides, while participants will receive two booklets of the slides. The supplements (PFS and MMS) will be given for 90 days duration, and a package of 30 days’ supplements will be given at the training and another 60 days’ package will be delivered at week four and eight.</i_keyword>
      <i_keyword>Control group. The control group will receive firstly, the Government food supplements (GFS), approximately 60 grams cookies that contain 300 kcal energy, 3 grams protein, and 22-30 grams fat. The GFS is fortified with multiple micronutrition, namely energy 300 Kcal , Total fat  15.6 g, Protein   3 g, Carbohydrate 34.8 g, Natrium 141 mg, Vitamin A  275.22 RE, Vitamin D  7.5 mcg, Vitamin E 7.08 mg, Vitamin B1 0.48 mg, Vitamin B2 0.48 mg, Vitamin B3  5.34 mg, Vitamin B5  1.8 mg, Vitamin B6  0.54 mg, Vitamin B9  198 mcg, Vitamin B12  0.84 mcg, Vitamin C 28.2 mg, Calcium   261.6 mg, Phosphor  194.4 mg, iron  6.96 mg, Iodium 51.6 mg, Zink  4.2 mg, Selenium 19.2 mcg, Fluor 0.18 mg,  water  1.764 g. Secondly, a 1-day class training on maternal health and early life nutrition. The trainers will be from PHCs and the researchers. The trainers will be provided with PowerPoint presentation slides, while participants will receive two booklets of the slides. The GFS will be given for 90 days duration, and a package of 30 days’ supplements will be given at the training and another 60 days’ package will be delivered at week four and eight.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Birth length of the baby born by the mother. Timepoint: 1-3 days after birth. Method of measurement: Measured by baby length board of SECA.</prim_outcome>
      <prim_outcome>Birthweight. Timepoint: 1-3 days after birth. Method of measurement: Measured by SECA baby's digital scale.</prim_outcome>
      <prim_outcome>Mode of delivery. Timepoint: 1-3 days after birth. Method of measurement: Hospital/PHC record.</prim_outcome>
      <prim_outcome>Maternal MUAC. Timepoint: after 90 days of intervention. Method of measurement: Measured on the non-dominant arm without sleeved garment using non-stretch tape made of fibreglass.</prim_outcome>
      <prim_outcome>Gestational weight gain. Timepoint: after 90 days of intervention. Method of measurement: Measured by SECA digital scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Birthweight. Timepoint: 1-3 days after birth. Method of measurement: Measured with digital scale of SECA Brand.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semarang Health Polytechnic</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-25</approval_date>
        <contact_name>HEALTH RESEARCH ETHICS COMMITTEE  POLTEKKES KEMENKES SEMARANG</contact_name>
        <contact_address>Jl. Tirto Agung, Pedalangan, Banyumanik, Semarang Semarang Central Java Indonesia</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
